Zoetis Inc. — Director's Dealing 2013

Jul 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2013-06-26

Reporting Person: Beaty Sandra J. (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-26	Common Stock	I	574	—	Acquired	574	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000	Direct

Footnotes

F1: Represents shares of Zoetis Inc. Common Stock acquired by the Reporting Person in the offer by Pfizer Inc. to exchange up to 400,985,000 shares of Zoetis Inc. Common Stock for outstanding shares of Pfizer Inc. common stock that were validly tendered and not validly withdrawn (the "Exchange Offer"), as more fully described in a registration statement on Form S-4 (File No. 333-188750) originally filed by the Issuer with the Securities and Exchange Commission on May 22, 2013 and declared effective on June 17, 2013.

F2: The Reporting Person acquired 574 shares of Zoetis Inc. Common Stock in exchange for 587 shares of Pfizer Inc. common stock pursuant to a registered exchange offer to Pfizer shareholders commenced by Pfizer on May 22, 2013. The closing price of a share of Pfizer Inc. common stock on the New York Stock Exchange on June 21, 2013, the trading day immediately preceding the day on which Pfizer accepted Pfizer shares that had been validly tendered and not validly withdrawn, was $28.46. The shares tendered for exchange were held under the Pfizer Inc. Savings and Investment Plan, a Rule 16b-3 plan.

F3: To be held in the Zoetis Inc. Savings Plan, a 401(k) plan.